CARDIOVASCULAR EFFECTS OF AN ARGINASE II SELECTIVE INHIBITOR
For the first time in vitro experiments there were studied the inhibitory activity and safety of potential molecules arginase II selective inhibitors from the group of norleucine derivatives. Also first the substance under the code ZB49-0010C from the group of norleucine derivatives showed the great...
Main Authors: | Vladimir Yakushev, Mikhail Pokrovskii |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2016-09-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.pensoft.net/article/31082/download/pdf/ |
Similar Items
-
STUDY OF THE PHARMACOLOGICAL ACTIVITY OF LOWMOLECULAR ARGINASE II SELECTIVE INHIBITOR USING A MODEL OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION
by: Liliya V. Korokina, et al.
Published: (2019-03-01) -
ENDOTHELIOPROTECTIVE AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR
by: V. I. Yakushev, et al.
Published: (2015-06-01) -
Synthesis of Arginase Inhibitors: An Overview
by: Maria Cristina Molaro, et al.
Published: (2025-01-01) -
RETRACTED: Arginase II - a new target in the development of endothelium protectors
by: V. I. Yakushev, et al.
Published: (2018-02-01) -
PHARMACOLOGICAL EFFICACY OF AN INHIBITOR OF ARGINASE-2 KUD975 WITH L-NAME-INDUCED ENDOTHELIAL DYSFUNCTION
by: Konstantin Kudryavtsev, et al.
Published: (2017-03-01)